Munzing Timothy
Family Medicine Residency Program Director for the Kaiser Permanente Orange County Area in Santa Ana, CA. Dr Munzing has more than ten years of experience as a Medical Expert Consultant for the Drug Enforcement Administration, the Medical Board of California, and other law enforcement agencies.
Perm J. 2017;21:16-169. doi: 10.7812/TPP/16-169.
Prescription opioid use for relief of noncancer pain has risen dramatically in the last 15 years, contributing to a quadrupling of opioid overdoses and prescription opioid-related deaths. This crisis is resulting in heightened attention by health care professionals and organizations, law enforcement, and the government. In this article, I highlight key topics in the management of patients using opioids (or potentially needing opioids) in outpatient clinical practice; federal and state law enforcement actions regarding physicians' illegal prescribing of opioids; multimodal approaches to pain control; nonmedication management of pain; response strategies when suspecting a patient of diverting or misusing opioids; and warning signs for abuse or diversion. For those patients for whom opioids are appropriate, I describe key elements for prescribing, including documentation of a detailed history and examination, appropriate evaluation to arrive at a specific diagnosis, individualizing management, and ongoing monitoring (including the use of urine drug screening and a prescription drug monitoring program). In addition to individual action, when possible, the initiation of systemwide and clinicwide safe prescribing practices supports the physician and patient such that the patient's well-being is at the heart of all pain management decisions. Physicians are encouraged to further educate themselves to treat pain safely and effectively; to screen patients for opioid use disorder and, when diagnosed, to connect them with evidence-based treatment; and to follow Centers for Disease Control and Prevention guidelines whenever possible.
在过去15年中,用于缓解非癌性疼痛的处方阿片类药物使用量急剧上升,导致阿片类药物过量使用及与处方阿片类药物相关的死亡人数增至四倍。这场危机正引起医疗保健专业人员与机构、执法部门及政府的高度关注。在本文中,我将重点介绍门诊临床实践中使用阿片类药物(或可能需要阿片类药物)的患者管理中的关键主题;联邦和州执法部门针对医生非法开具阿片类药物的行动;疼痛控制的多模式方法;疼痛的非药物管理;怀疑患者存在阿片类药物转移或滥用情况时的应对策略;以及滥用或转移的警示信号。对于那些适合使用阿片类药物的患者,我将描述处方的关键要素,包括详细病史和检查的记录、做出特定诊断的适当评估、个体化管理以及持续监测(包括使用尿液药物筛查和处方药监测计划)。除了个人行动外,在可能的情况下,启动全系统和全诊所的安全处方做法可支持医生和患者,使患者的福祉成为所有疼痛管理决策的核心。鼓励医生进一步自我教育,以安全有效地治疗疼痛;筛查患者是否患有阿片类药物使用障碍,一旦确诊,将他们与循证治疗联系起来;并尽可能遵循疾病控制与预防中心的指南。